Hidehisa Shimizu
- Molecular Biology top 10%
- Nephrology top 0.5%
- Physiology top 5%
- Immunology top 10%
- Surgery
- Co-authors
- Toshimitsu NiwaFuyuhiko NishijimaDilinaer BolatiAtsushi EnomotoHitoshi MiyazakiMaimaiti YisireyiliYukihiro HigashiyamaAyinuer Adijiang
- Topics
- Eicosanoids and Hypertension Pharmacology (8 papers)Neutrophil, Myeloperoxidase and Oxidative Mechanisms (7 papers)Peroxisome Proliferator-Activated Receptors (7 papers)
- Journals
- Journal of Biological ChemistrySHILAP Revista de lepidopterologíaScientific Reports
- Partner nations
- JapanGhanaSouth Korea
In The Last Decade
Hidehisa Shimizu
67 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 107
- Molecular Biology 957
- Nephrology 910
- Physiology 403
- Immunology 276
- Surgery 225
Countries citing papers authored by Hidehisa Shimizu
This map shows the geographic impact of Hidehisa Shimizu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidehisa Shimizu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidehisa Shimizu more than expected).
Fields of papers citing papers by Hidehisa Shimizu
This network shows the impact of papers produced by Hidehisa Shimizu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidehisa Shimizu. The network helps show where Hidehisa Shimizu may publish in the future.
Co-authorship network of co-authors of Hidehisa Shimizu
This figure shows the co-authorship network connecting the top 25 collaborators of Hidehisa Shimizu. A scholar is included among the top collaborators of Hidehisa Shimizu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidehisa Shimizu. Hidehisa Shimizu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 2 | |
| 4 | 13 | |
| 5 | 8 | |
| 6 | 3 | |
| 7 | 25 | |
| 8 | 1 | |
| 9 | 3 | |
| 10 | 32 | |
| 11 | 3 | |
| 12 | 17 | |
| 13 | 50 | |
| 14 | 137 | |
| 15 | 65 | |
| 16 | 62 | |
| 17 | 57 | |
| 18 | 92 | |
| 19 | 28 | |
| 20 | 28 |
About Hidehisa Shimizu
Hidehisa Shimizu is a scholar working on Nephrology, Biochemistry and Immunology, having authored 70 papers that have together received 2.4k indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (8 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (7 papers) and Peroxisome Proliferator-Activated Receptors (7 papers). The work is most often cited by research in Nephrology (910 citations), Biological Psychiatry (81 citations) and Clinical Biochemistry (159 citations). Hidehisa Shimizu has collaborated with scholars based in Japan, Ghana and South Korea. Frequent co-authors include Toshimitsu Niwa, Fuyuhiko Nishijima, Dilinaer Bolati, Atsushi Enomoto, Hitoshi Miyazaki, Maimaiti Yisireyili, Yukihiro Higashiyama, Ayinuer Adijiang, Gulinuer Muteliefu and Shinichi Saito. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.